KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 129 filers reported holding KEROS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $41 | -28.1% | 901 | +3.9% | 0.00% | – |
| Q1 2024 | $57 | -54.0% | 867 | -72.2% | 0.00% | -100.0% |
| Q4 2023 | $124 | +17.0% | 3,122 | -6.2% | 0.00% | 0.0% |
| Q3 2023 | $106 | -20.9% | 3,329 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $134 | +16.5% | 3,329 | +24.0% | 0.00% | 0.0% |
| Q1 2023 | $115 | -26.3% | 2,684 | -17.3% | 0.00% | 0.0% |
| Q4 2022 | $156 | -99.9% | 3,245 | +15.6% | 0.00% | 0.0% |
| Q3 2022 | $106,000 | +45.2% | 2,806 | +6.5% | 0.00% | 0.0% |
| Q2 2022 | $73,000 | -47.1% | 2,635 | +3.7% | 0.00% | 0.0% |
| Q1 2022 | $138,000 | – | 2,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 292,833 | $17,134,000 | 5.65% |
| Deep Track Capital, LP | 1,300,000 | $76,063,000 | 5.37% |
| Octagon Capital Advisors LP | 340,214 | $19,906,000 | 3.87% |
| Opaleye Management Inc. | 265,750 | $15,549,000 | 3.30% |
| First Light Asset Management, LLC | 552,098 | $32,303,000 | 2.31% |
| Altium Capital Management LP | 116,000 | $6,787,000 | 1.87% |
| Nantahala Capital Management | 796,698 | $46,615,000 | 1.64% |
| Orbimed Advisors | 1,679,417 | $98,263,000 | 1.26% |
| Darwin Global Management, Ltd. | 111,500 | $6,524,000 | 1.00% |
| Parkman Healthcare Partners LLC | 69,861 | $4,088,000 | 0.90% |